Deutsche Märkte öffnen in 4 Stunden 39 Minuten

Aditxt, Inc. (ADTX)

NasdaqCM - NasdaqCM Verzögerter Preis. Währung in USD
Zur Watchlist hinzufügen
1,9900-0,0100 (-0,50%)
Börsenschluss: 04:00PM EDT
1,9700 -0,02 (-1,01%)
Nachbörse: 07:31PM EDT

Aditxt, Inc.

737 North Fifth Street
Suite 200
Richmond, VA 23219
United States
650 870 1200
https://www.aditxt.com

Sektor(en)Healthcare
BrancheBiotechnology
Vollzeitmitarbeiter47

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Amro A. AlbannaCo-Founder, Chairman & CEO472,12kN/A1970
Dr. Shahrokh Shabahang D.D.S., M.S., Ph.D.Co-Founder, Chief Innovation Officer, Secretary & Director323,5kN/A1963
Mr. Thomas J. Farley CPAChief Financial Officer357,89kN/A1973
Ms. Corinne D. Pankovcin CPA, M.B.A.Chief Commercialization Officer366,77kN/A1966
Ms. Rowena AlbannaChief Operating OfficerN/AN/A1966
Ms. Jennifer LeeDirector of Human ResourcesN/AN/AN/A
Dr. Dolly B. Tyan Ph.D.Senior Vice President of Clinical Development – TransplantationN/AN/AN/A
Mr. Ge Chen M.D., M.S.Senior Vice President of Preclinical Research & DiscoveryN/AN/AN/A
Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Aditxt, Inc., a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.

Corporate Governance

Aditxt, Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.